People Caring for Aging Parents Can Win $2,000 of Free Hou... (visit http://www.agi About Merry Maid...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

People Caring for Aging Parents Can Win $2,000 of Free Housecleaning

Date:11/13/2008

visit http://www.agingcare.com or call 239-594-3202.

About Merry Maids

Merry Maids is the largest home cleaning franchise network in the world, and cleans more than 300,000 homes, apartments and condos in North America every month. Merry Maids is a part of the ServiceMaster(R) Family of Brands, which serves more than 10.5 million customers through market-leading commercial and residential service brands including Terminix, TruGreen, American Home Shield, AmeriSpec, Furniture Medic and ServiceMaster Clean. For more information on residential cleaning, visit the Merry Maids Web site at http://www.merrymaids.com or call 1-800-MERRYMAIDS.

SOURCE AgingCare.com
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. Over 50 percent of people with high blood pressure unaware they have condition
2. Foot Problems Common Among People With Diabetes
3. People with Diabetes Urged to Have Their Hearing Checked Regularly
4. MTVs Staying Alive Marks Ten Years of Empowering Young People in Their Fight against HIV and AIDS
5. More than 2,000 People Climb to Top of Chicagos Sears Tower
6. Statin Might Help More People Fight Heart Disease Than Thought
7. 5,000 People Expected to March to End Homelessness in Los Angeles County
8. 50,000 Young People Dance to Celebrate Achievements in Pushing Back HIV and AIDS
9. More People Living Longer After Cancer Diagnosis
10. National Multiple Sclerosis Society New Jersey Metro Chapter Looking for People to Join the Movement
11. Keppra XR(TM) Offers Convenient Dosing For People With Partial Onset Seizures

Post Your Comments:

Breaking Medicine News(10 mins):Health News:Procter & Gamble Announces Appointment of Director 2 Health News:Possible ovarian cancer treatment target identified 2 Health News:Testosterone Gets Bad Rap: Study 2 Health News:Testosterone Gets Bad Rap: Study 3 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20 Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21 Health News:People living in poorer neighborhoods at increased risk for death, worse health risks 2

[0] Procter & Gamble Announces Appointment of Director [0] Possible ovarian cancer treatment target identified [0] Testosterone Gets Bad Rap: Study [0] Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries)[0] People living in poorer neighborhoods at increased risk for death, worse health risks

Other Medicine News:Health News:Clot-Busting Treatment Improves Bleeding Stroke Outcomes 2 Health News:Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 2 Health News:Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 3 Health News:Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 4 Health News:Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin 5 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 2 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 3 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 4 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 5 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 6 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 7 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 8 Health News:FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder 9 Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 2 Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 3 Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 4 Health News:AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia 5 Health News:THE Aesthetic Show Advances $34 Billion Market 2 Health News:THE Aesthetic Show Advances $34 Billion Market 3 Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 2 Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 3 Health News:Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds 4

Clot-Busting Treatment Improves Bleeding Stroke Outcomes Masimo Receives FDA Clearance for Noninvasive Total Hemoglobin FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder AEterna Zentaris Announces First Patient Dosing for Safety Trial of Phase 3 Program with Cetrorelix in Benign Prostatic Hyperplasia THE Aesthetic Show Advances $34 Billion Market Forty-Five Percent of U.S. Employees Have Gained Weight at Their Current Jobs, CareerBuilder.com Study Finds

Breaking Medicine Technology:Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 2 Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 3 Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 4 Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 5 Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 6 Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries) 7 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 2 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 3 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 4 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 5 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 6 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 7 Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective 8 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 2 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 3 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 4 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 5 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 6 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 7 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 8 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 9 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 10 Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 11 Neuroimaging provides insights into new treatment options for Alzheimers disease 61064 1 Emotions increase or decrease pain 3A researchers 61059 1 Emotions increase or decrease pain 3A researchers 61059 2 Limeade Wellness Program Chosen to Serve Washington State Employees 61055 1 Limeade Wellness Program Chosen to Serve Washington State Employees 61055 2

[0] Reportlinker Adds European Markets for Drug Eluting and Bare Metal Stents 2009 (15 Countries)[0] Reportlinker Adds Cardiac Biomarkers - A Global Market Perspective [0] Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review

Other Medicine Technology:Eurand Announces Positive Phase III Clinical Study Results 2 Eurand Announces Positive Phase III Clinical Study Results 3 Eurand Announces Positive Phase III Clinical Study Results 4 Eurand Announces Positive Phase III Clinical Study Results 5 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 2 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 3 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 4 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 5 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 6 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 7 Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer 8

Eurand Announces Positive Phase III Clinical Study Results Survival Data Available from Erbitux Study in First-Line Treatment,of Advanced Head and Neck Cancer

Medicine Products:

Wies Chalazion Forceps Drews Cilia Forceps Gradle Cilia Forceps Demarres Chalazion Forceps - 24 mm